Related Experiment Video

Updated: Mar 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Managing the lipid profile of coronary heart disease patients

Maria Drakopoulou1, Konstantinos Toutouzas1, Konstantinos Stathogiannis1

  • 1a First Department of Cardiology , Medical School of Athens University, Hippokration Hospital , Athens , Greece.

Expert Review of Cardiovascular Therapy
|August 24, 2016
PubMed

Insights

Managing lipid profiles is crucial for secondary prevention in coronary heart disease patients. Current guidelines present disputes impacting clinical practice, necessitating updated strategies for better patient outcomes.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Lipid profile management is critical for secondary prevention in patients with established coronary heart disease.
  • These patients face a higher risk of cardiovascular events.
  • Current guidelines emphasize lifestyle modification and patient engagement.

Purpose of the Study:

  • To summarize current recommendations for lipid profile management in coronary heart disease patients.
  • To present lifestyle modifications and novel treatment strategies.
  • To highlight areas of dispute among recent guidelines.

Main Methods:

  • Review of current guidelines from major cardiology organizations.
  • Analysis of lifestyle modification recommendations.
  • Discussion of emerging pharmacological treatments.

Main Results:

  • Significant differences exist between current and previous guidelines, impacting clinical practice.
  • Controversies in treatment goals and therapeutic decisions are noted.
  • Ongoing randomized controlled trials are evaluating new lipid-lowering drugs.

Conclusions:

  • Discrepancies in guidelines may affect patient management strategies.
  • Further research and clinical trials are needed to clarify optimal lipid management.
  • Novel therapeutic agents show promise for future treatment.
Abstract

Keywords:
Secondary preventioncoronary heart diseaselipid managementlipid-lowering drugsstatins

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
798
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
376
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363